Dates: 05 March 2021
The Long-Acting/Extended Release (LA/ER) Antiretroviral Research Resource Program (LEAP) pre-CROI Investigator Meeting and Annual Workshop was held virtually on Friday 5 March 2021, with the objective to discuss the recent advances in the long-acting field, novel applications and related approaches for the treatment and prevention of HIV, viral hepatitis and tuberculosis.
The Medicines Patent Pool (MPP) was invited to address some of the access issues that long-acting technologies and their formulations may face in low- and middle-income countries (LMICs), and to propose possible interventions to overcome this bottleneck.
MPP is working towards fostering development and broadening access to long-acting technologies in order to facilitate access to these ground-breaking therapeutics by:
More information on LEAP programme supported by the division of AIDS, NIAID
More information on MPP’s long-acting therapeutics initiative below:
Lobna Gaayeb
Head of Scientific and Medical Affairs (Geneva)
News & Press Releases » News
MedinCell proposes a long-acting solution to malaria transmission and collaborates with the Medicines Patent Pool
University of Liverpool and University of Washington forge the way in revolutionary long-acting medicines
The Medicines Patent Pool and Unitaid publish intellectual property report on long-acting technologies
News & Press Releases » Events
AIDS 2020 SATELLITE SYMPOSIUM: Harnessing access to long-acting technologies in low- and middle-income countries. Are we on track to resolving the conundrum?
MPP co-sponsored with Medincell a conference on Long-Acting Injectables and Implantables